Anthrax Vaccines

Pre- and post-exposure vaccines

This page catalogs 2 anthrax vaccine products. Anthrax vaccines have historically been used primarily for military and occupational populations at risk of exposure to Bacillus anthracis.

Last updated: April 2026.

Anthrax Vaccine Catalog

Trade Name Generic Designation Manufacturer Vaccine Type Regulatory Status & Year Key Notes
BioThrax Anthrax vaccine adsorbed (AVA) Emergent BioSolutions Adsorbed subunit FDA Licensed, 1970 Only US-licensed anthrax vaccine for pre-exposure
Cyfendus Anthrax vaccine adsorbed, adjuvanted (AV7909) Emergent BioSolutions Subunit + CpG adjuvant FDA Licensed, 2023 Post-exposure prophylaxis with antibiotics

Sources

Regulatory data sourced from FDA CBER Vaccines Licensed for Use in the United States (March 2026). Catalog scope informed by Khan, Shaz, The Ultimate Vaccine Timeline.

Related Pages on VaccinationFacts.com

Vaccine Catalog

Browse all vaccine categories

Vaccine History Timeline

Milestones in vaccine development